This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.
Get full access to this article
View all access options for this article.
References
1.
StoneN.J.Fish consumption, fish oil, lipids, and coronary heart disease. Circulation.1996; 94(9): 2337–2340.
2.
BangH.O., DyerbergJ.Advances in Nutrition Research.New York, NY: Plenum Press; 1980; 1–22.
3.
DolecekT.A., GranditisG.Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet.1991; 66: 205–216.
4.
KagawaY., NishizawaM., SuzukiM.. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol (Tokyo).1982; 28(4): 441–453.
5.
KromhoutD., FeskensE.J., BowlesC.H.The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol.1995; 24(2): 340–345.
6.
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet.1999; 354(9177): 447–455.
7.
YokoyamaM., OrigasaH., MatsuzakiM.. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded end-point analysis. Lancet.2007; 369(9567): 1090–1098.
8.
NilsenD.W., AlbrektsenG., LandmarkK., MoenS., AarslandT., WoieL.Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr.2001; 74(1): 50–56.
9.
MozaffarianD., RimmE.B.Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA.2006; 296(15): 1885–1899.
10.
Kris-EthertonP.M., HarrisW.S., AppelL.J.Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation.2002; 106(21): 2747–2757.
11.
LeafA., AlbertC.M., JosephsonM.. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation.2005; 112(18): 2762–2768.
12.
RaittM.H., ConnorW.E., MorrisC.. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA.2005; 293(23): 2884–2891.
13.
BrouwerI.A., ZockP.L., CammA.J.. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA.2006; 295(22): 2613–2619.
14.
CalòL., BianconiL., ColivicchiF.. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol.2005; 45(10): 1723–1728.
15.
ThiesF., GarryJ.M., YaqoobP.. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet.2003; 361(9356): 477–485.
16.
McKenneyJ.M., SicaD.Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy.2007; 27(5): 715–728.
17.
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation.2002; 106(25): 3143–3421.
18.
HilbertG., LillemarkL., BalchenS., HøjskovC.S.Reduction of organochlorine contaminants from fish oil during refining. Chemosphere.1998; 37(7): 1241–1252.
19.
Omega-3 oil: fish or pills?Consum Rep.2003; 68: 30–32.
20.
JacobsM.N., SantilloD., JohnstonP.A., WyattC.L., FrenchM.C.Organochlorine residues in fish oil dietary supplements: comparison with industrial grade oils. Chemosphere.1998; 37(9-12): 1709–1721.
21.
GoodnightS.H.Jr, HarrisW.S., ConnorW.E.The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood.1981; 58(5): 880–885.
22.
KnappH.R.Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr.1997; 65(5 suppl): 1687S–1698S.
23.
BenderN.K., KraynakM.A., ChiquetteE.. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis.1998; 5(3): 257–261.
24.
EritslandJ., ArnesenH., GrønsethK., FjeldN.B., AbdelnoorM.Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol.1996; 77(1): 31–36.
25.
McKenneyJ.M., SwearingenD., Di SpiritoM.. Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters. J Clin Pharmacol.2006; 46(7): 785–791.
26.
MorrisM.C., SacksF., RosnerB.Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation.1993; 88(2): 523–533.
FriedbergC.E., JanssenM.J., HeineR.J., GrobbeeD.E.Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care.1998; 21(4): 494–500.
29.
LuoJ., RizkallaS.W., VidalH.. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care.1998; 21(5): 717–724.
30.
SirtoriC.R., CrepaldiG., ManzatoE.. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis.1998; 137(2): 419–427.
31.
SirtoriC.R., PaolettiR., ManciniM.. N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study. Am J Clin Nutr.1997; 65(6): 1874–1881.
